Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
NPJ Breast Cancer|February 19, 2022
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancerIlenia Migliaccio, Marta Paoli, Emanuela Risi, et al.
Therapeutic Advances in Medical Oncology|June 15, 2018
The role of abemaciclib in treatment of advanced breast cancerAmelia McCartney, Erica Moretti, Giuseppina Sanna, et al.
Cancer Treatment Reviews|December 28, 2020
CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancerIlenia Migliaccio, Martina Bonechi, Amelia McCartney, et al.
Breast (Edinburgh, Scotland)|January 12, 2018
First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM studyAngelo Di Leo, Guy Jerusalem, Roberto Torres, et al.
Communications Biology|November 3, 2021
Charting differentially methylated regions in cancer with Rocker-methMatteo Benelli, Gian Marco Franceschini, Alberto Magi, et al.
Breast Care (Basel, Switzerland)|December 14, 2017
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of ResponseCristina Guarducci, Martina Bonechi, Giulia Boccalini, et al.
Cancer Treatment Reviews|February 2, 2019
The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise reviewLorenzo Rossi, Amelia McCartney, Irene De Santo, et al.
Clinical Breast Cancer|July 31, 2019
Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast CancerLorenzo Rossi, Amelia McCartney, Emanuela Risi, et al.
International Journal of Molecular Sciences|April 30, 2021
Precision Oncology via NMR-Based Metabolomics: A Review on Breast CancerAlessia Vignoli, Emanuela Risi, Amelia McCartney, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
The continued evidence from overviews: what is the clinical utility?Natalie Turner, Laura Biganzoli, Luca Malorni, et al.
Pageof 7